Ocuphire Pharma Inc. buy me8
Start price
30.06.21
/
0%
€5.00
Target price
30.06.22
€8.00
Performance (%)
-22.40%
End price
09.07.21
€3.88
Summary
This prediction ended on 09.07.21 with a price of €3.88. The price of Ocuphire Pharma Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.40%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocuphire Pharma Inc. | 2.145% | 2.145% | 85.874% | -31.973% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to me8 what are the pros and cons of Ocuphire Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Cons
Little innovation
Comments by me8 for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Buy Ocuphire Pharma Inc.
Kursziel gesetzt auf 8,0